BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough therapies for cardiovascular and muscle disease based on microRNA biology, today announced that its Chief Scientific Advisor and co-founder, Eric N. Olson, Ph.D., received the American Heart Association National Research Achievement Award. Dr. Olson, Professor and Chairman of the Department of Molecular Biology at the University of Texas Southwestern Medical Center, was honored for making major discoveries identifying molecular mechanisms that control normal and abnormal growth and development of the heart and cardiovascular system. In addition, he presented the American Heart Association Plenary Distinguished Scientist Lecture titled, “MicroRNA Control of Heart Disease: From New Biology to New Therapeutics,” at the Association’s Scientific Sessions 2008. miRagen Therapeutics is commercializing the fundamental discoveries made in Olson’s laboratory on microRNAs whose dysregulation is associated with cardiovascular and muscle disease.
